Dr Luis Vazquez, DO | |
2340 E Beardsley Rd, Suite 260, Phoenix, AZ 85024-1285 | |
(602) 802-8240 | |
(602) 802-8245 |
Full Name | Dr Luis Vazquez |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 15 Years |
Location | 2340 E Beardsley Rd, Phoenix, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437387883 | NPI | - | NPPES |
923114 | Medicaid | AZ |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Elite Ent | 5890073803 | 2 |
News Archive
To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.
Terahertz (THz) radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks.
Just listening to Irene Ingemi describe the patchwork system of friends, family, and part-time day-care services she's stitched together to help her care for her frail mother-in-law is exhausting.
For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.
Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatric oncologist at Helen DeVos Children's Hospital and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), DFMO, an investigational agent, showed minimal side effects with long-term survival of three patients.
› Verified 3 days ago
Entity Name | Feliz Family Care Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538533799 PECOS PAC ID: 3274838586 Enrollment ID: O20160224002680 |
News Archive
To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.
Terahertz (THz) radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks.
Just listening to Irene Ingemi describe the patchwork system of friends, family, and part-time day-care services she's stitched together to help her care for her frail mother-in-law is exhausting.
For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.
Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatric oncologist at Helen DeVos Children's Hospital and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), DFMO, an investigational agent, showed minimal side effects with long-term survival of three patients.
› Verified 3 days ago
Entity Name | Elite Ent |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457801300 PECOS PAC ID: 5890073803 Enrollment ID: O20161026001519 |
News Archive
To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.
Terahertz (THz) radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks.
Just listening to Irene Ingemi describe the patchwork system of friends, family, and part-time day-care services she's stitched together to help her care for her frail mother-in-law is exhausting.
For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.
Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatric oncologist at Helen DeVos Children's Hospital and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), DFMO, an investigational agent, showed minimal side effects with long-term survival of three patients.
› Verified 3 days ago
Entity Name | Happy Kids Pediatrics Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821288606 PECOS PAC ID: 8426322504 Enrollment ID: O20170928001435 |
News Archive
To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.
Terahertz (THz) radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks.
Just listening to Irene Ingemi describe the patchwork system of friends, family, and part-time day-care services she's stitched together to help her care for her frail mother-in-law is exhausting.
For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.
Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatric oncologist at Helen DeVos Children's Hospital and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), DFMO, an investigational agent, showed minimal side effects with long-term survival of three patients.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Luis Vazquez, DO 2340 E Beardsley Rd, Suite 260, Phoenix, AZ 85024-1285 Ph: (602) 802-8240 | Dr Luis Vazquez, DO 2340 E Beardsley Rd, Suite 260, Phoenix, AZ 85024-1285 Ph: (602) 802-8240 |
News Archive
To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.
Terahertz (THz) radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks.
Just listening to Irene Ingemi describe the patchwork system of friends, family, and part-time day-care services she's stitched together to help her care for her frail mother-in-law is exhausting.
For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.
Researchers at Spectrum Health Helen DeVos Children's Hospital have completed the first clinical trial of a new treatment for children suffering from neuroblastoma. In a clinical trial led by Giselle Sholler, MD, pediatric oncologist at Helen DeVos Children's Hospital and the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), DFMO, an investigational agent, showed minimal side effects with long-term survival of three patients.
› Verified 3 days ago
Dr. Shawn Michael Stevens, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave # 330, Phoenix, AZ 85013 Phone: 602-406-8811 Fax: 602-406-8810 | |
Charles R Orozco, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4250 E Camelback, Suite K-250, Phoenix, AZ 85018 Phone: 602-253-9026 Fax: 602-252-6391 | |
John David Macias, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1515 N 9th St, Suite B, Phoenix, AZ 85006 Phone: 602-257-4228 Fax: 602-252-6416 | |
Dr. Michael L Hinni, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Randy Oppenheimer, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Department Of Surgery, Phoenix, AZ 85008 Phone: 602-344-5608 Fax: 602-344-1299 | |
Austin N Dehart, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1920 E Cambridge Ave Ste 201, Phoenix, AZ 85006 Phone: 602-933-3277 Fax: 602-933-4326 | |
Griffin Santarelli, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2910 N 3rd Ave # 330, Phoenix, AZ 85013 Phone: 602-406-8811 Fax: 602-406-8810 |